U.S. top court rejects Maryland bid to revive drug price-gouging law
WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday rejected Maryland's bid to revive a law aimed at preventing price gouging by pharmaceutical companies, dealing a setback to the power of states to rein in prescription drug costs.